Evidence map›Paper›PMID 25184303›Full record

ArticlePloS one2014

A pentasymmetric open channel blocker for Cys-loop receptor channels.

Valentina Carta, Michael Pangerl, Roland Baur, Roshan Puthenkalam, Margot Ernst, Dirk Trauner, Erwin Sigel

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Valentina CartaInstitute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland.
Michael PangerlDepartment of Chemistry, Ludwig-Maximilians-Universität München and Center of Integrated Protein Science, Munich, Germany.
Roland BaurInstitute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland.
Roshan PuthenkalamDepartment of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria.
Margot ErnstDepartment of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria.
Dirk TraunerDepartment of Chemistry, Ludwig-Maximilians-Universität München and Center of Integrated Protein Science, Munich, Germany.
Erwin SigelInstitute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland.
University of Bern · CHLudwig-Maximilians-Universität München · DEMedical University of Vienna · AT

Funding

Austrian Science Fund FWF W 1232
6 · The paper itself

Abstract

γ-Aminobutyric acid type A receptors (GABAA receptors) are chloride ion channels composed of five subunits, mediating fast synaptic and tonic inhibition in the mammalian brain. These receptors show near five-fold symmetry that is most pronounced in the second trans-membrane domain M2 lining the Cl- ion channel. To take advantage of this inherent symmetry, we screened a variety of aromatic anions with matched symmetry and found an inhibitor, pentacyanocyclopentdienyl anion (PCCP-) that exhibited all characteristics of an open channel blocker. Inhibition was strongly dependent on the membrane potential. Through mutagenesis and covalent modification, we identified the region α1V256-α1T261 in the rat recombinant GABAA receptor to be important for PCCP- action. Introduction of positive charges into M2 increased the affinity for PCCP- while PCCP- prevented the access of a positively charged molecule into M2. Interestingly, other anion selective cys-loop receptors were also inhibited by PCCP-, among them the Drosophila RDL GABAA receptor carrying an insecticide resistance mutation, suggesting that PCCP- could serve as an insecticide.

Indexed as

Amino Acid SubstitutionAnimalsDrosophila melanogasterDrosophila ProteinsGABA-A Receptor AntagonistsMutation, MissenseProtein Structure, SecondaryProtein Structure, TertiaryRatsReceptors, GABA-ADrosophila ProteinsGABA-A Receptor AntagonistsReceptors, GABA-A

Identifiers

PMID25184303
PMCPMC4153658
OpenAlexW1974417618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.